Cargando…
PROTAC chemical probes for histone deacetylase enzymes
Over the past three decades, we have witnessed the progression of small molecule chemical probes designed to inhibit the catalytic active site of histone deacetylase (HDAC) enzymes into FDA approved drugs. However, it is only in the past five years we have witnessed the emergence of proteolysis targ...
Autores principales: | Patel, Urvashi, Smalley, Joshua P., Hodgkinson, James T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10467623/ https://www.ncbi.nlm.nih.gov/pubmed/37654508 http://dx.doi.org/10.1039/d3cb00105a |
Ejemplares similares
-
Optimization of
Class I Histone Deacetylase PROTACs
Reveals that HDAC1/2 Degradation is Critical to Induce Apoptosis and
Cell Arrest in Cancer Cells
por: Smalley, Joshua P., et al.
Publicado: (2022) -
A ‘click’ chemistry approach to novel entinostat (MS-275) based class I histone deacetylase proteolysis targeting chimeras
por: Cross, Jasmine M., et al.
Publicado: (2022) -
Comprehensive
Transcriptomic Analysis of Novel Class
I HDAC Proteolysis Targeting Chimeras (PROTACs)
por: Baker, India M., et al.
Publicado: (2022) -
Chemical Phylogenetics of Histone Deacetylases
por: Bradner, James E., et al.
Publicado: (2010) -
Real-time detection of histone deacetylase activity with a small molecule fluorescent and spectrophotometric probe
por: Rooker, Debra R., et al.
Publicado: (2015)